Next, we wanted to evaluate whether PD1 ARMed CAR T cells could overcome the limitations of CNS-localized tumors and could outperform CAR T cells in the D270 orthotopic GBM xenograft NSG mouse model, where combination with anti-PD1 Ab therapy failed. Here, PDCD1 is linked to glioblastoma.